Andreas T J Vogg (Andreas Vogg)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Metastatic Breast Cancer

Direct Oral Anticoagulants

Venous Thromboembolism

Top Venues

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Ramya Ambur Sankaranarayanan, Jennifer Peil, Andreas T J Vogg, Carsten Bolm, Steven Terhorst, Arno Classen, Matthias Bauwens, Jochen Maurer, Felix Manuel Mottaghy, Agnieszka Morgenroth
Correction: Sankaranarayanan et al. Auger Emitter Conjugated PARP Inhibitor for Therapy in Triple Negative Breast Cancers: A Comparative In-Vitro Study. Cancers 2022, 14 , 230. Cancers 15 (9) (2023)
Ramya Ambur Sankaranarayanan, Jennifer Peil, Andreas T J Vogg, Carsten Bolm, Steven Terhorst, Arno Classen, Matthias Bauwens, Jochen Maurer, Felix Manuel Mottaghy, Agnieszka Morgenroth
Correction: Sankaranarayanan et al. Auger Emitter Conjugated PARP Inhibitor for Therapy in Triple Negative Breast Cancers: A Comparative In-Vitro Study. Cancers 2022, 14 , 230. Cancers 15 (9) (2023)
Ramya Ambur Sankaranarayanan, Jennifer Peil, Andreas T J Vogg, Carsten Bolm, Steven Terhorst, Arno Classen, Matthias Bauwens, Jochen Maurer, Felix Manuel Mottaghy, Agnieszka Morgenroth
Auger Emitter Conjugated PARP Inhibitor for Therapy in Triple Negative Breast Cancers: A Comparative In-Vitro Study. Cancers 14 (1) (2022)
Daniel Kang, Ulrich Simon, Felix Manuel Mottaghy, Andreas T J Vogg
Labelling via [Al18F]2+ Using Precomplexed Al-NODA Moieties. Pharmaceuticals (Basel, Switzerland) 14 (8) (2021)
Alexandru Florea, Julius P Sigl, Agnieszka Morgenroth, Andreas T J Vogg, Sabri Sahnoun, Oliver H Winz, Jan Bucerius, Leon J Schurgers, Felix Manuel Mottaghy
Sodium [18F]Fluoride PET Can Efficiently Monitor In Vivo Atherosclerotic Plaque Calcification Progression and Treatment. Cells 10 (2) (2021)